Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tonix Pharmaceuticals

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

What's Going On With Tonix Pharmaceuticals Shares Today?

What's Going On With Tonix Pharmaceuticals Shares Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 6.03% to $2.96 during Thursday’s pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a Chatham, New Jersey-based clinical-stage biopharmaceutical company, announced on Wednesday the issuance of a patent that forms the basis for the company's developmental vaccine against monkeypox and smallpox.

Recap: Tonix Pharmaceuticals Q1 Earnings

Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Tonix Pharmaceuticals Rockets Higher Thursday: Why Is The Penny Stock Flying?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the treatment of Prader-Willi syndrome.

inkl

Read news from The Economist, FT, and more,
with one subscription

Tonix Pharma Inks Research Pact For Oxytocin In Eating Disorder

Tonix Pharma Inks Research Pact For Oxytocin In Eating Disorder

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Delta Air Lines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

250,829 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play